340 likes | 615 Views
Role of colonic stent in the management malignant colonic obstruction Dr Eddy Lo TKOH JHSGR Aug 2011. Introduction. Colorectal cancer is a common and important health issue in HK Rank 2 nd in the crude cancer incidence 2 nd commonest cause of cancer related death
E N D
Role of colonic stent in the management malignant colonic obstruction Dr Eddy Lo TKOH JHSGR Aug 2011
Introduction • Colorectal cancer is a common and important health issue in HK • Rank 2nd in the crude cancer incidence • 2nd commonest cause of cancer related death (HK cancer registry 2008)
Introduction • ~10%-30% of patients with colorectal cancer present with features of IO Deans GT et al. Malignant obstruction of the left colon. Br J Surg 1994;81:1270-76 • 70% occurs in left colon Philips RK et al. Malignant large bowel obstruction. Br J Surg 1985;72:296- 302 • Poor 5-year OS for those presented with IO, ~20% • Ohman U. Prognosis in patients with obstructing colorectal carcinoma. Am J 1982;143:742-7 • Significant no. of patients will end up with a stoma • Impact on QoL
Introduction • Traditional Mx • Surgery • Rt colon: colectomy + primary anastomosis • Lt colon: controversial • two/three stage operation • One stage operation + on-table colonic irrigation • Colonic stenting +/- interval elective operation
Colonic stent • First used by Dohomoto in 1990 to manage the acute phase of malignant colonic obstruction Dohomoto M et al. Endoscopically-implanted prosthesis in rectal carcinoma. Dtsch Med Wochenschr 1990;115:915 • Self expandable metallic non-covered stent (nitinol or stainless steel) of various diameter and length • e.g. Wallstent • Covered stent has high rate of migration
Colonic stent • Indications • Temporary colonic decompression • Bridge to elective surgery • Palliation • Contraindications • Clinical/radiological evidence of perforation • Unfavorable anatomy
Post-stenting • Monitor vital signs • Observe for any BO • Take an AXR the next day to assess the stent position and expansion • Check electrolytes • +/- arrange elective operation in ~2-3 weeks after the patient is stabilized
Colonic stent • Technical and clinical success rate ~90% Cause of failure • Failure to negotiate through tumor due to complete obstruction • Poor stent position • Perforation • Mean durations of stent patency ~106 days Watt AM et al. self-expanding metallic stents for relieving malignant colorectal obstruction. A systemic review. Ann Surg 2007;246:24-30
Complications • Mild • Radiation exposure • PR bleeding • Severe bleeding 2.5% Selinger CP et al. Long-term success of colonic stent insertion is influendced by indication but not by length of stent or site of obstruction. Int J Colorectal Dis 2011;26:215-8 • Pain • Temporary incontinence • Faecal impaction • Harris G et al. The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices. Am J Surg 2001;181:499-506
Complications • Severe • Perforation • 4.5% • Procedure related • Unsuccessful decompression • Migration • 11% • Obstruction after initial decompression • 10% • Tumor ingrowth • Migration of stent Watt AM et al. self-expanding metallic stents for relieving malignant colorectal obstruction. A systemic review. Ann Surg 2007;246:24-30
Complications • Stent fracture • IO • Perforation • Khot U et al. Systemic review of the efficacy and safety of colorectal stents. Br J Surg 2002;89:1096-1102 • Stent-related mortality • 1% Sebastian S et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004;99:2051-7
Limitations • Distal rectal tumor • Severe tenemus • Faecal incontinence Turegano F et al. Transanal self-expanding metal stents as an alternative to palliative colostomy in selected patients with malignant obstruction of the left colon. Br J Surg 1998;85:232-5
Why stenting? • Emergency operation entails substantial operative mortality and morbidity • Colonic stenting decreases mortality rate and medical complications Tilney HS et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc 2007;21:225-233 • No sig. difference in 3-yr (50% vs. 48%) or 5-yr (44% vs. 40%) OS Saida Y et al. Long-term prognosis of preoperative ‘bridge to surgery’ expandable metallic stent insertion for obstructive colorectal cancer: comparison with emergency operation. Dis Colon Rectum 2003;46:S44-49
Why stenting? • No significant difference in recurrence Beltran JM et al. Left obstructive colonic carcinoma. Comparative study of short and middle-term results after a new therapeutic procedure based in self-expanding metallic stents placement. Zaragoza, Spain: Universidad de Zaragoza 2003 • Prevent 84.6% of colostomies • Decrease total hospital stay, ICU stay and lower complication rate Martinez C et al. Self-expandable stent before elective surgery vs emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 2002;45:401-406
Why stenting? • Greater successful 1-stage operation • Less cumulative blood loss • Less wound infection • Reduced incidence of anastomotic leak • Greater LN harvest • Higher rate of primary anastomosis Cheung HYS et al. Endolaparoscopic approach vs. convertional open surgery in the treatment of obstructing left-sided colon cancer. Arch Surg 2009;144(12):1127-32
Why stenting? • Enable laparoscopic assisted operation • Less invasive to multistage operation • Faster recovery Stipa F et al. Management of obstructive colorectal cancer with endoscopic stenting followed by single-stage surgery: open or laparoscopic resection? Surg Endosc 2008;22:1477-1481 • Allow early administration of chemotherapy in patients with disseminated diseases Karoui M et al. Stents for palliation of obstructive metastatic colon cancer. Arch Surg 2007;142(7):619-623
Cost • SFI in HA, ~$8000 • Lower mean cost per patient in stenting group than emergency operation • Fewer operative procedure/patient (1.01 vs. 1.32) • Shorter hospital stay • 83% reduction in stoma requirement (7% vs. 43%) • Less complication Binkert CA et al. Acute colonic obstruction: clinical aspects and cost-effectiveness of preoperative and palliative treatment with self-expanding metallic stents – a preliminary report. Radiology 1998;206:199-204 Targownik LE et al. Colonic stent vs. emergency for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest Endosc 2004;60:865-74
Recommendations • Consensus conference of the world society of emergency surgery and peritoneum and surgery society 2010 • Colonic stent • Preferred to colostomy for palliation of obstructing left colon cancer (2B) • Used as a bridge to elective surgery (1B)
However…. • Several recent RCTs showed in the stenting group • high Cx rate i.e. perforation • failed to demostrate benefits Van Hooft JE et al. Early closure of a multicenter randomized clincial trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 2008 Mar; 40(3):184-91 Pirlet IA et al. Emergency preoperative stenting versus surgery for acute left-sided malignant colonic obstruction: a multicenter randomized controlled trial. Surg Endosc 2011;25:1814-21 Van Hooft JE et al. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: A multicentre randomized trial. Lancet Oncol 2011;12:344-52
However… • Studies carried out in small volume centre, ~3 patients/yr/centre received colonic stents • Comparing to previous reviews • Higher perforation rate • Highter technical failure rate
However… • Risk factors for perforation • Chemotherapy • RT • Steroid • Dilatation Datye A et al. Colonic perforation after stent placement for malignant colorectal obstruction—causes and contributing factors. Minim Invasive Ther Technol 2011 May;20(3):133-40
Conclusion • Colonic stent placement is a safe and effective measure in the management of malignant colonic obstruction • Palliation • Bridge to elective surgery • Careful patient selection • Yet to be proven by large scale RCT